Structures by: Tutughamiarso M.
Total: 51
C4H4FN3O,C4H5N3
C4H4FN3O,C4H5N3
Acta Crystallographica Section B (2012) 68, 4 431-443
a=6.2414(12)Å b=7.2335(17)Å c=11.546(2)Å
α=105.371(18)° β=101.944(16)° γ=91.700(18)°
2(C4H4FN3O),C6H9N3O2
2(C4H4FN3O),C6H9N3O2
Acta Crystallographica Section B (2012) 68, 4 431-443
a=7.6548(12)Å b=9.3233(14)Å c=12.848(2)Å
α=83.406(12)° β=83.529(12)° γ=81.420(12)°
C4H4FN3O,C4H5N3O2
C4H4FN3O,C4H5N3O2
Acta Crystallographica Section B (2012) 68, 4 431-443
a=15.5508(15)Å b=11.7839(7)Å c=11.4971(12)Å
α=90.00° β=101.660(8)° γ=90.00°
C4H4FN3O,C4H6N4O,H2O
C4H4FN3O,C4H6N4O,H2O
Acta Crystallographica Section B (2012) 68, 4 431-443
a=8.3280(12)Å b=9.3484(14)Å c=9.4779(15)Å
α=61.797(11)° β=64.500(11)° γ=67.138(11)°
C4H4FN3O,C8H11N5O3
C4H4FN3O,C8H11N5O3
Acta Crystallographica Section B (2012) 68, 4 431-443
a=7.0859(5)Å b=9.0414(5)Å c=22.8754(16)Å
α=90.00° β=98.155(6)° γ=90.00°
C4H4FN3O,C2H5N3O2,C2H6OS
C4H4FN3O,C2H5N3O2,C2H6OS
Acta Crystallographica Section B (2012) 68, 4 444-452
a=8.4065(17)Å b=8.9045(18)Å c=10.6441(19)Å
α=111.163(15)° β=96.337(15)° γ=105.703(16)°
C6H7N3O3
C6H7N3O3
Acta Crystallographica Section B (2012) 68, 4 444-452
a=11.4303(12)Å b=7.1695(8)Å c=8.9753(11)Å
α=90.00° β=102.194(9)° γ=90.00°
C4H4FN3O,C5H7N3O,H2O
C4H4FN3O,C5H7N3O,H2O
Acta Crystallographica Section B (2012) 68, 4 444-452
a=5.1193(8)Å b=9.3392(15)Å c=12.4862(19)Å
α=97.103(12)° β=93.662(13)° γ=95.766(13)°
C6H9N3O2
C6H9N3O2
Acta Crystallographica Section B (2012) 68, 4 431-443
a=7.9835(14)Å b=10.0664(12)Å c=9.8380(16)Å
α=90.00° β=111.266(13)° γ=90.00°
C4H4FN3O,C6H7N3O3,C2H6OS
C4H4FN3O,C6H7N3O3,C2H6OS
Acta Crystallographica Section B (2012) 68, 4 444-452
a=9.4478(9)Å b=23.7171(16)Å c=7.2635(7)Å
α=90.00° β=96.700(8)° γ=90.00°
2(C4H4FN3O),C4H6N4O,C3H7NO
2(C4H4FN3O),C4H6N4O,C3H7NO
Acta Crystallographica Section B (2012) 68, 4 431-443
a=11.2283(11)Å b=15.1837(12)Å c=18.8290(17)Å
α=71.262(7)° β=87.187(8)° γ=88.460(7)°
C5H7N3O,C4H6N4O,2(C4H9NO)
C5H7N3O,C4H6N4O,2(C4H9NO)
Acta Crystallographica Section B (2012) 68, 4 444-452
a=6.9824(11)Å b=9.1224(14)Å c=17.651(3)Å
α=88.329(12)° β=89.875(12)° γ=75.513(12)°
1-(Pyridin-2-yl)thiourea
C6H7N3S
Acta Crystallographica Section E (2007) 63, 12 o4682-o4682
a=14.0116(13)Å b=6.1820(4)Å c=16.8726(15)Å
α=90.00° β=97.140(7)° γ=90.00°
4-Ethyl-4-methylpiperidine-2,6-dione
C8H13NO2
Acta Crystallographica Section E (2007) 63, 12 o4743-o4743
a=11.128(2)Å b=6.6820(10)Å c=11.311(2)Å
α=90.00° β=98.375(15)° γ=90.00°
Dimethyl 3,4-dihydroxy-1<i>H</i>-pyrrole-2,5-dicarboxylate
C8H9NO6
Acta Crystallographica Section E (2007) 63, 12 o4742-o4742
a=10.1782(10)Å b=12.4456(8)Å c=7.1922(8)Å
α=90.00° β=96.080(9)° γ=90.00°
5-fluorocytosine dimethyl sulfoxide solvate
C4H4FN3O,C2H6OS
Acta Crystallographica Section C (2009) 65, 11 o574-o578
a=12.4467(12)Å b=9.1849(8)Å c=8.5635(8)Å
α=90.00° β=107.065(8)° γ=90.00°
5-fluorocytosine dimethylacetamide hemisolvate
C4H4FN3O,0.5C4H9NO
Acta Crystallographica Section C (2009) 65, 11 o574-o578
a=7.7247(12)Å b=8.2840(13)Å c=13.238(2)Å
α=90.204(13)° β=104.336(12)° γ=107.774(12)°
5-fluorocytosine hemihydrate
C4H4FN3O,0.5H2O
Acta Crystallographica Section C (2009) 65, 11 o574-o578
a=14.7039(13)Å b=12.4546(10)Å c=13.7921(14)Å
α=90.00° β=115.474(7)° γ=90.00°
Nitrofurantoin dimethyl sulfoxide monosolvate
C8H6N4O5,C2H6OS
Acta Crystallographica Section C (2011) 67, 1 o18-o25
a=6.6257(4)Å b=26.488(2)Å c=8.0032(5)Å
α=90.00° β=100.347(5)° γ=90.00°
Nitrofurantoin dimethylacetamide monosolvate
C8H6N4O5,C4H9NO
Acta Crystallographica Section C (2011) 67, 1 o18-o25
a=16.2038(16)Å b=7.4215(5)Å c=13.1195(12)Å
α=90.00° β=111.681(7)° γ=90.00°
2,6-diacetaminopyridine dimethylformamide monosolvate
C9H11N3O2,C3H7NO
Acta Crystallographica Section C (2011) 67, 1 o18-o25
a=11.3031(7)Å b=13.1539(8)Å c=9.3959(5)Å
α=90.00° β=94.327(5)° γ=90.00°
Nitrofurantoin dimethylacetamide disolvat
C8H6N4O5,2(C4H9NO)
Acta Crystallographica Section C (2011) 67, 1 o18-o25
a=20.874(2)Å b=11.5433(9)Å c=8.7162(9)Å
α=90.00° β=100.708(9)° γ=90.00°
Nitrofurantoin--2,6-diacetaminopyridine (1/1)
C8H6N4O5,C9H11N3O2
Acta Crystallographica Section C (2011) 67, 1 o18-o25
a=9.8407(6)Å b=17.9443(10)Å c=10.9902(6)Å
α=90.00° β=97.839(5)° γ=90.00°
2,6-diaminopyrimidin-4-one
C4H6N4O
Acta Crystallographica Section C (2011) 67, 5 o179-o187
a=7.7150(9)Å b=9.7229(7)Å c=7.4514(8)Å
α=90.00° β=114.453(8)° γ=90.00°
2-amino-6-methylpyrimidin-4(3<i>H</i>)-one—–2-amino-6-methylpyrimidin-\ 4(1<i>H</i>)-one—–dimethylacetamide (1/1/1)
2(C5H7N3O),C4H9NO
Acta Crystallographica Section C (2011) 67, 5 o179-o187
a=7.8763(13)Å b=9.6078(17)Å c=12.3115(19)Å
α=108.780(13)° β=95.194(13)° γ=99.959(13)°
2,6-diaminopyrimidin-4-one <i>N</i>-methyl-2-pyrrolidone solvate (3/2)
2(C4H6N4O),3(C5H9NO)
Acta Crystallographica Section C (2011) 67, 5 o179-o187
a=8.4550(9)Å b=10.0803(9)Å c=17.0735(15)Å
α=75.558(7)° β=78.222(8)° γ=81.363(8)°
2,6-diaminopyrimidin-4-one dimethylacetamide solvate (1/1)
C4H6N4O,C4H9NO
Acta Crystallographica Section C (2011) 67, 5 o179-o187
a=19.1494(13)Å b=7.8704(4)Å c=14.9104(11)Å
α=90.00° β=104.868(6)° γ=90.00°
2-amino-6-methylpyrimidin-4(3<i>H</i>)-one—–2-amino-6-methylpyrimidin-\ 4(1<i>H</i>)-one—–<i>N</i>-methyl-2-pyrrolidone (1/1/1)
2(C5H7N3O),C5H9NO
Acta Crystallographica Section C (2011) 67, 5 o179-o187
a=7.3321(7)Å b=9.8805(9)Å c=12.5860(12)Å
α=102.835(7)° β=98.830(8)° γ=91.555(8)°
Chelidamic acid methanol monosolvate
C7H5NO5,CH4O
Acta Crystallographica Section C (2012) 68, 9 o344-o350
a=5.8256(5)Å b=12.5648(12)Å c=12.7464(11)Å
α=90.00° β=100.303(7)° γ=90.00°
Chelidamic acid dimethyl ester monohydrate
C9H9NO5,H2O
Acta Crystallographica Section C (2012) 68, 9 o344-o350
a=17.241(3)Å b=6.1519(12)Å c=20.710(4)Å
α=90.00° β=107.96(3)° γ=90.00°
Dimethylammonium chelidamate
C2H8N,C7H4NO5
Acta Crystallographica Section C (2012) 68, 9 o344-o350
a=7.3688(8)Å b=11.1416(12)Å c=14.3584(15)Å
α=69.025(8)° β=79.438(9)° γ=72.455(9)°
Chelidamic acid dimethyl sulfoxide monosolvate
C7H5NO5,C2H6OS
Acta Crystallographica Section C (2012) 68, 9 o344-o350
a=4.7460(4)Å b=10.4917(9)Å c=11.9787(11)Å
α=103.592(7)° β=97.606(7)° γ=101.651(7)°
2-aminopyrimidine--6-propyl-2-thiouracil (1/2)
C4H5N3,2(C7H10N2OS)
Acta Crystallographica Section C (2011) 67, 11 o439-o445
a=7.6094(5)Å b=12.9888(6)Å c=20.8838(14)Å
α=90.00° β=99.179(5)° γ=90.00°
6-propyl-2-thiouracil
C7H10N2OS
Acta Crystallographica Section C (2011) 67, 11 o439-o445
a=10.4340(6)Å b=11.1320(6)Å c=28.7090(17)Å
α=90.00° β=90.00° γ=90.00°
<i>N</i>-(6-acetamidopyridin-2-yl)acetamide--6-propyl-2-thiouracil (1/2)
C9H11N3O2,2(C7H10N2OS)
Acta Crystallographica Section C (2011) 67, 11 o439-o445
a=37.9355(12)Å b=76.880(3)Å c=10.5666(3)Å
α=90.00° β=90.00° γ=90.00°
2,4-diamino-5(4-chlorophenyl)-6-ethylpyrimidine
C12H13ClN4
Acta Crystallographica Section C (2011) 67, 11 o428-o434
a=14.4471(18)Å b=7.5774(7)Å c=11.7526(15)Å
α=90.00° β=107.279(10)° γ=90.00°
Hydantoin-5-acetic acid
C5H6N2O4
Acta Crystallographica Section C (2012) 68, 2 o92-o98
a=7.6148(5)Å b=8.5592(6)Å c=9.3406(6)Å
α=90.00° β=90.00° γ=90.00°
Orotic acid dimethyl sulfoxide monosolvate
C5H4N2O4,C2H6OS
Acta Crystallographica Section C (2012) 68, 2 o92-o98
a=9.3710(6)Å b=5.9752(3)Å c=17.8433(13)Å
α=90.00° β=97.447(6)° γ=90.00°
2,4-diamino-5(4-chlorophenyl)-6-ethylpyrimidine dimethyl sulfoxide monosolvate
C12H13ClN4,C2H6OS
Acta Crystallographica Section C (2011) 67, 11 o428-o434
a=13.5596(9)Å b=7.7212(4)Å c=16.2870(11)Å
α=90.00° β=111.609(5)° γ=90.00°
2,4-diamino-5(4-chlorophenyl)-6-ethylpyrimidine <i>N</i>-methylpyrrolidin-2-one monosolvate
C12H13ClN4,C5H9NO
Acta Crystallographica Section C (2011) 67, 11 o428-o434
a=9.5221(14)Å b=10.8372(15)Å c=18.650(2)Å
α=101.937(11)° β=99.555(11)° γ=98.892(12)°
5,5'-(5-(4-chlorophenyl)-6-ethylpyrimidine-2,4-diyl)bis(azanediyl)bis(1- methylpyrrolidin-2-one)
C22H27ClN6O2
Acta Crystallographica Section C (2011) 67, 11 o428-o434
a=6.7742(6)Å b=9.2265(8)Å c=17.3345(15)Å
α=95.363(7)° β=92.435(7)° γ=93.783(7)°
Dimethylammonium orotate--orotic acid (1/1)
C2H8N,C5H3N2O4,C5H4N2O4
Acta Crystallographica Section C (2012) 68, 2 o92-o98
a=8.1110(10)Å b=8.9503(11)Å c=11.6804(15)Å
α=112.366(3)° β=97.263(2)° γ=104.621(2)°
Dimethylammonium orotate--orotic acid (3/1)
3(C2H8N),3(C5H3N2O4),C5H4N2O4
Acta Crystallographica Section C (2012) 68, 2 o92-o98
a=7.0176(14)Å b=18.026(4)Å c=12.906(3)Å
α=90.00° β=94.94(3)° γ=90.00°
Creatinine dimethyl sulfoxide monosolvate
C4H7N3O,C2H6OS
Acta Crystallographica Section E (2010) 66, 11 o2714
a=5.8997(10)Å b=7.3018(13)Å c=11.276(2)Å
α=75.861(18)° β=83.763(16)° γ=79.694(13)°
1-(4-Fluorophenyl)biguanid-1-ium chloride
C8H11FN5,Cl
Acta Crystallographica Section E (2010) 66, 10 o2648
a=6.9954(5)Å b=9.2187(4)Å c=16.3149(11)Å
α=90.00° β=91.111(5)° γ=90.00°
C4H4FN3O,C4H6N4O,C3H7NO
C4H4FN3O,C4H6N4O,C3H7NO
Acta Crystallographica Section B (2012) 68, 4 431-443
a=9.0866(14)Å b=9.3632(15)Å c=9.4019(15)Å
α=104.720(13)° β=94.340(13)° γ=102.010(13)°
C8H11N5O3
C8H11N5O3
Acta Crystallographica Section B (2012) 68, 4 431-443
a=10.9182(11)Å b=11.1666(8)Å c=7.9786(9)Å
α=90.00° β=108.346(8)° γ=90.00°
2(C4H4FN3O),2(C4H6N4O),C3H7NO
2(C4H4FN3O),2(C4H6N4O),C3H7NO
Acta Crystallographica Section B (2012) 68, 4 431-443
a=7.1894(12)Å b=10.0991(15)Å c=10.9953(19)Å
α=104.970(10)° β=105.330(10)° γ=110.850(10)°
Nitrofurantoin dimethylacetamide monosolvate
C8H6N4O5,C4H9NO
Acta Crystallographica Section C (2011) 67, 1 o18-o25
a=6.6544(5)Å b=7.9842(6)Å c=14.3515(11)Å
α=100.021(6)° β=93.566(6)° γ=99.274(6)°
Nitrofurantoin dimethyl sulfoxide hemisolvate
C8H6N4O5,0.5(C2H6OS)
Acta Crystallographica Section C (2011) 67, 1 o18-o25
a=16.1710(11)Å b=13.7985(8)Å c=10.3465(8)Å
α=90.00° β=102.358(6)° γ=90.00°
2,6-diaminopyrimidin-4-one dimethylformamide solvate hydrate (3/4/1)
(C4H6N4O),4/3(C3H7NO),1/3(H2O)
Acta Crystallographica Section C (2011) 67, 5 o179-o187
a=7.4417(6)Å b=25.3217(18)Å c=9.8578(7)Å
α=90.00° β=108.476(6)° γ=90.00°